The neuropharmacology of impulsive behaviour
- PMID: 18304658
- DOI: 10.1016/j.tips.2008.01.002
The neuropharmacology of impulsive behaviour
Abstract
Impulsivity is a heterogenous phenomenon encompassing several behavioural phenomena that can be dissociated neuroanatomically as well as pharmacologically. Impulsivity is pathological in several psychiatric disorders including attention-deficit/hyperactivity disorder (ADHD), drug addiction and personality disorders. Pharmacological agents alleviating impulsivity therefore might substantially aid the treatment of these disorders. The availability of preclinical models that measure various forms of impulsivity has greatly increased our understanding of its neuropharmacological substrates. Historically, deficits in central serotonin neurotransmission are thought to underlie impulsivity. Accumulating evidence also points towards an important role of brain dopamine and noradrenaline systems in impulsive behaviour, consistent with the therapeutic efficacy of amphetamine, methylphenidate and atomoxetine in ADHD. However, recent findings also implicate glutamate and cannabinoid neurotransmission in impulsivity. In this review, we will discuss some of the recent developments in the neuropharmacological manipulation of impulsive behaviour.
Similar articles
-
Dopaminergic modulation of the orbitofrontal cortex affects attention, motivation and impulsive responding in rats performing the five-choice serial reaction time task.Behav Brain Res. 2010 Jul 11;210(2):263-72. doi: 10.1016/j.bbr.2010.02.044. Epub 2010 Mar 3. Behav Brain Res. 2010. PMID: 20206211
-
Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).Prog Brain Res. 2008;172:543-65. doi: 10.1016/S0079-6123(08)00926-6. Prog Brain Res. 2008. PMID: 18772050 Review.
-
Serotonergic functioning and trait-impulsivity in attention-deficit/hyperactivity-disordered boys (ADHD): influence of rapid tryptophan depletion.Hum Psychopharmacol. 2008 Jan;23(1):43-51. doi: 10.1002/hup.896. Hum Psychopharmacol. 2008. PMID: 17926336 Clinical Trial.
-
Pharmacological manipulation of memory reconsolidation: towards a novel treatment of pathogenic memories.Eur J Pharmacol. 2008 May 13;585(2-3):453-7. doi: 10.1016/j.ejphar.2008.03.010. Epub 2008 Mar 18. Eur J Pharmacol. 2008. PMID: 18410917 Review.
-
[Heredity and role of serotonin in aggressive impulsive behavior].Encephale. 1998 Jul-Aug;24(4):355-64. Encephale. 1998. PMID: 9809241 Review. French.
Cited by
-
Simulated synapse loss induces depression-like behaviors in deep reinforcement learning.Front Comput Neurosci. 2024 Nov 6;18:1466364. doi: 10.3389/fncom.2024.1466364. eCollection 2024. Front Comput Neurosci. 2024. PMID: 39569353 Free PMC article.
-
Borderline personality disorder and post-traumatic stress disorder in adolescents: protocol for a comparative study of borderline personality disorder with and without comorbid post-traumatic stress disorder (BORDERSTRESS-ADO).BMC Psychiatry. 2024 Oct 23;24(1):724. doi: 10.1186/s12888-024-06093-4. BMC Psychiatry. 2024. PMID: 39443885 Free PMC article.
-
Aberrant glutamatergic systems underlying impulsive behaviors: Insights from clinical and preclinical research.Prog Neuropsychopharmacol Biol Psychiatry. 2024 Dec 20;135:111107. doi: 10.1016/j.pnpbp.2024.111107. Epub 2024 Aug 2. Prog Neuropsychopharmacol Biol Psychiatry. 2024. PMID: 39098647 Review.
-
Trait Impulsivity as a Feature of Parkinson's Disease Treatment and Progression.Parkinsons Dis. 2024 May 11;2024:8770997. doi: 10.1155/2024/8770997. eCollection 2024. Parkinsons Dis. 2024. PMID: 38766569 Free PMC article. Review.
-
The novel peptide LCGM-10 attenuates metabotropic glutamate receptor 5 activity and demonstrates behavioral effects in animal models.Front Behav Neurosci. 2024 Feb 7;18:1333258. doi: 10.3389/fnbeh.2024.1333258. eCollection 2024. Front Behav Neurosci. 2024. PMID: 38385004 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources